Megaloblastic Anemia Nos

DBCOND0103581Hemic and Lymphatic DiseasesNutritional and Metabolic Diseases

Megaloblastic Anemia Nos is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Anaemia megaloblastic · Megaloblastic anemia · Anemia, Megaloblastic
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0001134ICD-10D53.1SNOMED CT154788000MedDRA10002065UMLSC0002888

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
14Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Megaloblastic Anemia Nos share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In